A targeted bacteriophage that selectively kills harmful gut bacteria without touching the good ones. Selectively infects and destroys specific strains of harmful gut bacteria without harming good bacteria or human cells.
Reviewed March 2026
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. LH01 Myoviridae Bacteriophage has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
LH01 is a lytic phage with a narrow host range against specific Escherichia coli strains, so it lyses those cells and frees nutrients and adhesion sites in the same intestinal niche. Co dosed probiotic strains, which the phage cannot infect, are the ones positioned to use that space.
Phage host range is strain specific and this coliform phage does not infect lactobacilli, so it removes a competing population without touching the delivered strain. That is the basis for pairing coliform phages with Lactobacillus in a single formula.
LH01 is a coliphage with a narrow host range, so it lyses specific Escherichia coli strains and leaves gram-positive commensals such as bifidobacteria untouched. Removing a competing population frees luminal nutrients and adhesion sites. That is the mechanistic basis for pairing a phage preparation with a probiotic rather than a measured result for this combination.
Bacteriophages recognise their host through specific surface receptors, and a coliphage cannot adsorb to a Bifidobacterium cell. The probiotic therefore passes through unaffected while the phage acts on its own target. Formulators use that specificity to combine the two in one capsule.
Lactobacillus species are gram-positive and outside the host range of a coliphage, so co-administration does not put the probiotic at risk. The pairing is the usual commercial format for phage preparations. Whether the combination changes anything measurable beyond the probiotic alone is not established in the candidate literature.
Bacteriophages infect bacteria only, so a yeast preparation is entirely outside the phage host range. The two act on different parts of the gut community with no direct interaction. Read the pairing as compatible rather than synergistic.
Inulin feeds bifidobacteria and other saccharolytic commensals, while a phage reduces a specific competing population. Making space and feeding the residents are complementary moves on the same community. The reasoning is ecological and the combined effect has not been quantified.
Short-chain fructooligosaccharides are fermented in the proximal colon by bifidobacteria. A phage acting on a competing coliform in the same region complements that selective feeding. The pairing is standard in synbiotic-style formulas.
Galactooligosaccharides support bifidobacterial growth and also act as decoy receptors for some bacterial adhesins in the lumen. Combined with a host-specific phage, both work on which organisms dominate rather than on the host directly. This is mechanism, not a measured combination.
Resistant starch reaches the colon intact and feeds butyrate-producing communities. Phage-driven changes to community composition and substrate-driven changes act on the same ecosystem from different directions. Short-chain fatty acid output is a marker of fermentation, not an outcome by itself.
Partially hydrolysed guar gum is a well tolerated fermentable fibre that shifts the fermenting population. Pairing it with a phage preparation stacks two ways of changing which organisms dominate. Grounding is ecological and confidence stays low.
Butyrate supplied directly acts on colonocyte energy metabolism, while a phage acts on the composition of the community that would otherwise produce it. The two reach the same endpoint from opposite ends. No study in the candidate set measured the pair.
Glutamine is the preferred fuel of enterocytes and supports normal tight junction protein expression, which is a host-side effect. A phage acts on the luminal bacterial community, which is a microbial-side effect. Formulas combine them for that split, and the split is the whole rationale.
Bovine colostrum supplies immunoglobulins and oligosaccharides that bind bacterial adhesins in the lumen. A phage reduces specific host bacteria by lysis. Both act on bacterial populations without being absorbed, though nothing in the candidate literature measures them together.
Zinc carnosine adheres to the mucosal surface and is studied for support of normal mucosal integrity, a host-tissue effect. The phage acts in the lumen on bacteria. Combining a host-side and a microbe-side ingredient is formulation logic rather than a demonstrated interaction.
Slippery elm mucilage forms a viscous layer over the mucosal surface, which can slow diffusion of particles including phage through to the epithelial interface. Whether that matters for a lumen-acting phage is unknown. The row exists to flag the physical consideration, not to claim an effect.
Tailed phages lose infectivity at gastric pH, and most preparations are formulated to survive transit. Raising gastric pH transiently with bicarbonate reduces the acid load a phage particle meets. This is a survival-of-the-particle argument taken from phage stability work, not a measured gain in effect.
Betaine hydrochloride is taken deliberately to lower gastric pH, which is the condition under which tailed phage particles are most rapidly inactivated. Taking the two in the same dose is working against the phage. Separating them by a couple of hours is the straightforward answer.
A phage capsid and tail are made of protein, and supplemental proteases including pepsin and pancreatin degrade protein in the lumen. High-strength protease taken at the same time can reduce the number of intact particles reaching the colon. The concern is mechanistic and depends on formulation and enteric protection.
Activated charcoal has an enormous adsorptive surface and binds particles and macromolecules non-selectively in the gut lumen. Phage particles are large protein assemblies and are the sort of material charcoal adsorbs. Taking the two together is likely to reduce the phage dose that stays free, so space them apart.
Bentonite is a charged aluminosilicate that binds proteins and viruses to its layered surface, a property used in water treatment. A phage preparation taken alongside it can be adsorbed and carried out. This is a physical binding issue and is straightforward to avoid by separating doses.
Broad-spectrum antimicrobial botanicals such as oregano oil reduce bacterial numbers indiscriminately, including the host bacteria a phage needs in order to replicate. Fewer hosts means less phage amplification in the gut. The interaction is inferred from phage biology rather than measured for this pair.
Lactoferrin sequesters iron and binds bacterial surface lipopolysaccharide, limiting growth of iron-dependent gram-negative organisms. A coliphage lyses a subset of the same group. Two different pressures on the same population, with no study in the candidate set measuring them together.
Talk to a doctor before taking LH01 Myoviridae Bacteriophage if any of these apply to you: Very limited clinical data for oral supplementation, Narrow host range. These are flags to check first, not effects LH01 Myoviridae Bacteriophage is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 7 we read for LH01 Myoviridae Bacteriophage. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.